SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is at the center of a major strategic shift after announcing the acquisition of Boeing's Wisk Aero, SkyGrid, and Insitu, a deal that integrates an established, profitable defense revenue stream with their existing eVTOL commercialization plans. While the community is actively debating the potential dilution impacts and long-term value of this expanded aerospace platform, traders are closely watching how this move influences upcoming earnings sentiment and the company's path toward autonomous flight.

Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Coherent Corp

Coherent Corp is experiencing heightened volatility and market attention as investors react to a sector-wide rotation, with community discourse heavily focused on long-term AI infrastructure demand versus short-term supply chain uncertainties. Supporters are closely monitoring the company's vertically integrated indium phosphide production as a key competitive advantage in the expanding optical and AI networking bottleneck.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is facing heightened market anticipation as investors await the long-delayed Phase 3 IZAR-1 clinical trial results for sonelokimab in psoriatic arthritis, with sentiment split between those expecting best-in-class efficacy and skeptics concerned about management's communication and timeline delays. The community is actively debating whether the upcoming data will justify a significant re-rating or trigger further downside, while institutionally-heavy ownership adds to the volatility and speculative pressure surrounding the stock's next major catalyst.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is trending as investors weigh its critical role in AI-driven optical infrastructure against recent volatility and sector-wide sentiment shifts. The community remains deeply divided, with bulls highlighting the stock's position in the AI networking supply chain and potential for long-term growth, while others express frustration over sharp technical pullbacks and price swings.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera is gaining momentum as investors anticipate imminent Phase 2 data for its lead menopause asset, ABCL635, which the community views as a critical de-risking catalyst. Sentiment is heavily divided between long-term holders encouraged by institutional partnerships and vocal critics pointing to past share price declines and the high-stakes binary nature of the upcoming clinical readout.

Bitdeer Technologies Group engages in the cryptocurrency mining industry. It generates income through its proprietary mining datacenters. The firm handles complex processes involved in computing such as equipment procurement, transport logistics, datacenter design and construction, equipment management, and daily operations. The company was founded by Wu Jihan in December 2021 and is headquartered in Singapore.

Bitdeer Technologies Group. - Ordinary Shares - Class A

Bitdeer Technologies Holding Co

Bitdeer Technologies is drawing intense community focus following the announcement of a massive 16-year data center lease in Norway, though the stock has struggled to maintain momentum amidst broader sector volatility. Investors are actively debating the company's long-term pivot toward AI and HPC infrastructure, with many looking for a definitive 'show-me' catalyst like a signed contract with a major hyperscaler to trigger a valuation re-rating.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is surging following news that its ultrasound-on-chip technology is being integrated into a new AI-powered full-body scanner developed by Midjourney. The community is actively debating the stock's long-term growth potential and high short interest versus risks of future dilution and potential profit-taking.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trending as investors react to strong quarterly performance and raised guidance, while the community actively debates whether the stock's premium valuation is justified by its leadership in AI-driven cybersecurity. Despite positive analyst sentiment and long-term bullish outlooks, recent price volatility has sparked intense discussion among traders weighing the balance between persistent enterprise security spending and the stock's significant appreciation.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is trending due to heightened investor focus on its 800G and 1.6T transceiver manufacturing ramp, as community members debate whether current production capacity can keep pace with accelerating AI optical-networking demand. While bulls highlight record revenue growth and a strong multi-year outlook, bears are actively debating valuation concerns and potential volatility surrounding upcoming earnings results.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics is trending following a significant 80 million dollar public offering priced at five dollars per share, which has sparked intense debate among investors regarding the resulting equity dilution and the company's long-term capital strategy. The community is actively weighing the potential impact of this cash infusion on the commercialization of Eversense 365 against concerns over share count expansion, management's fiscal track record, and the upcoming first-quarter earnings report.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ROLR retail is reading this wrong. Competitive pressure on ROLR in prediction markets is already baked into its current valuation. $HOOD.X isn’t a new player in this space that seeks to disrupt the big two. RH has offered this feature to users for over a year now, but they are a fintech company at the end of the day, focused on their brokerage and bank users. This is good news for ROLR because of increased liquidity, as you said. Same applies with anyone else that partners with OG/CDC. Prediction markets need widespread reach and tight spreads to be attractive and successful, so every new partnership with OG/CDC should be viewed as bullish. ROLR’s approach is likely going to be the same as its legacy iGaming business, which is asset-light in principle. That’s the edge. Low-cost, wide reach, and outsourced labor to enable focus on multiple revenue streams in responsible entertainment. They’re unlikely to pursue vertical integration like $DKNG. The only likely buyout candidate is $SAR.

StockRegulationBot

Tommy L.

$ROLR not sure the Robinhood with Crypto.com partnership would be good for ROLR.  Increased liquidity and exposure, but more immediate competition. Not sure how to feel about it.

Buy, sell, store, and trade over 400+ cryptocurrencies on Crypto.com, a secure and trusted crypto exchange platform.

Crypto.com: Buy, Sell & Trade Crypto with a Trusted App

StockTwits For Android 

High Roller Technologies Inc

Day La

StockTwits for iOS

ROBIN HOOD COIN

DraftKings Inc

Saratoga Investment Corp.

 retail is reading this wrong. Competitive pressure on ROLR in prediction markets is already baked into its current valuation. 

 isn’t a new player in this space that seeks to disrupt the big two. RH has offered this feature to users for over a year now, but they are a fintech company at the end of the day, focused on their brokerage and bank users. This is good news for ROLR because of increased liquidity, as you said. Same applies with anyone else that partners with OG/CDC. Prediction markets need widespread reach and tight spreads to be attractive and successful, so every new partnership with OG/CDC should be viewed as bullish. ROLR’s approach is likely going to be the same as its legacy iGaming business, which is asset-light in principle. That’s the edge. Low-cost, wide reach, and outsourced labor to enable focus on multiple revenue streams in responsible entertainment. They’re unlikely to pursue vertical integration like 

Aegialeuz

@Aegialeuz if you say so, but dkng is up 5% while rolr is down 6%, about 18% off the short term high. So I dunno man. Even with the NFA approval, it&#39;s not doing so well.

 if you say so, but dkng is up 5% while rolr is down 6%, about 18% off the short term high. So I dunno man. Even with the NFA approval, it's not doing so well.

@Deelam product isn’t out yet. There is no comparison.

 product isn’t out yet. There is no comparison.